Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptor protein- tyrosine kinases
Most Correlated Studies
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- Melanocytes with inducible oncogenic receptor Xmrk stimulated with EGF
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Most Relevant Literature
- VEGFR-3 signaling restrains the neuron-macrophage crosstalk during neurotropic viral infection.
- VEGFR3 suppression through miR-1236 inhibits proliferation and induces apoptosis in ovarian cancer v…
- Investigation of Targeting Relationship between Micro-Rna-22 and Vegfr3 in Lung Squamous Cell Carcin…
- Morphometric image analysis of vascular endothelial growth factor receptor-3 in preeclamptic, HIV in…
- Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dep…
Most Relevant Clinical Trials
- Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein…
- Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Sm…
- NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Rena…
- A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Me…
- VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumo…
